![PRD_001191 PRD_001191](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001191.svg) | PRD_001191 | Name: | iCAL36(BRB-K-1) peptide | Formula: | C58 H86 Br N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001192 PRD_001192](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001192.svg) | PRD_001192 | Name: | iCAL36(TFA-K-1) peptide | Formula: | C53 H82 F3 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001193 PRD_001193](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001193.svg) | PRD_001193 | Name: | iCAL36(FLB-K-1) peptide | Formula: | C58 H86 F N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001194 PRD_001194](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001194.svg) | PRD_001194 | Name: | iCAL36(Ac-K-5) peptide | Formula: | C48 H86 N15 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001195 PRD_001195](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001195.svg) | PRD_001195 | Name: | iCAL36(Ac-K-4) peptide | Formula: | C54 H89 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001196 PRD_001196](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001196.svg) | PRD_001196 | Name: | iCAL36(Ac-K-3) peptide | Formula: | C55 H89 N16 O15 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001197 PRD_001197](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001197.svg) | PRD_001197 | Name: | iCAL36(Ac-K-1) peptide | Formula: | C53 H85 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001232 PRD_001232](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001232.svg) | PRD_001232 | Name: | Alpha-conotoxin ImI mutant | Formula: | C54 H84 N20 O15 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_001251 PRD_001251](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001251.svg) | PRD_001251 | Name: | ACE-PHE-ALA-THR-ALA-0QE | Formula: | C22 H31 Cl N4 O6 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_001252 PRD_001252](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001252.svg) | PRD_001252 | Name: | ACE-ILE-ALA-THR-ALA-0QE | Formula: | C19 H33 Cl N4 O6 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_002092 PRD_002092](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002092.svg) | PRD_002092 | Name: | L-alanyl-3,5-dibromo-L-tyrosyl-L-alanine | Formula: | C15 H19 Br2 N3 O5 | Definition date: | 2014-07-08 | Last modified: | 2014-07-08 |
|
![PRD_001078 PRD_001078](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001078.svg) | PRD_001078 | Name: | Peptide inhibitor MPT-DPP-DAR-G-DPN-NH2 | Formula: | C23 H38 N9 O5 S | Definition date: | 2014-06-25 | Last modified: | 2014-06-25 |
|
![PRD_001181 PRD_001181](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001181.svg) | PRD_001181 | Name: | GE23077 | Formula: | C31 H49 N9 O16 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
![PRD_001216 PRD_001216](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001216.svg) | PRD_001216 | Name: | Somatostatin-14 | Formula: | C76 H108 N18 O19 S2 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
![PRD_001229 PRD_001229](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001229.svg) | PRD_001229 | Name: | anti-CmABCB1 peptide | Formula: | C100 H139 N24 O26 S | Definition date: | 2014-04-30 | Last modified: | 2014-04-30 |
|
![PRD_001086 PRD_001086](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001086.svg) | PRD_001086 | Name: | Microviridin J | Formula: | C80 H108 N19 O22 | Definition date: | 2014-04-02 | Last modified: | 2014-04-02 |
|
![PRD_001218 PRD_001218](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001218.svg) | PRD_001218 | Name: | Dityromycin | Formula: | C67 H88 N10 O16 | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | Definition date: | 2014-04-02 | Last modified: | 2014-04-02 |
|
![PRD_001142 PRD_001142](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001142.svg) | PRD_001142 | Name: | tyrocidine A | Formula: | C66 H87 N13 O13 | Definition date: | 2014-03-19 | Last modified: | 2014-03-19 |
|
![PRD_001104 PRD_001104](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001104.svg) | PRD_001104 | Name: | cyclic peptide S2iL5 | Formula: | C90 H126 F3 N27 O23 S | Definition date: | 2014-02-19 | Last modified: | 2014-02-19 |
|
![PRD_001185 PRD_001185](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001185.svg) | PRD_001185 | Name: | CONANTOKIN BK-B | Formula: | C46 H64 N10 O25 | Definition date: | 2014-02-19 | Last modified: | 2014-02-19 |
|
![PRD_001167 PRD_001167](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001167.svg) | PRD_001167 | Name: | bicyclic peptide UK811 | Formula: | C74 H119 N26 O22 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
![PRD_001168 PRD_001168](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001168.svg) | PRD_001168 | Name: | bicyclic peptide UK903 | Formula: | C72 H103 N19 O19 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
![PRD_001173 PRD_001173](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001173.svg) | PRD_001173 | Name: | Phosphothreonine ester-containing peptide | Formula: | C44 H72 N8 O13 P | Definition date: | 2013-10-30 | Last modified: | 2014-01-23 |
|
![PRD_001213 PRD_001213](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001213.svg) | PRD_001213 | Name: | PK(NLE)DN(DVA) peptide | Formula: | C30 H51 N8 O9 | Definition date: | 2013-12-25 | Last modified: | 2013-12-25 |
|
![PRD_001156 PRD_001156](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001156.svg) | PRD_001156 | Name: | PL-55 | Formula: | C41 H67 N9 O12 P S | Definition date: | 2013-12-11 | Last modified: | 2013-12-11 |
|